NCT05874167 - A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

October 11, 2022

Study Completion Date

October 11, 2022

Conditions

Healthy Subjects

Interventions

DRUG

DW6013

"Drug: DW6013 Single oral administration of DW6013 after an overnight fast~Drug: Linagliptin and Metformin Single oral administration of Linagliptin and Metformin after an overnight fast"

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si